nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adhesion proteins in cellular tight junctions: critical components in the modulation of paracellular permeability
|
Mrsny, Randall J. |
|
2005 |
|
6 |
p. 809-810 2 p. |
artikel |
2 |
Advanced screening assays to rapidly identify solubility-enhancing formulations: High-throughput, miniaturization and automation
|
Dai, Wei-Guo |
|
2008 |
|
6 |
p. 657-672 16 p. |
artikel |
3 |
Advances in lipid nanodispersions for parenteral drug delivery and targeting
|
Constantinides, Panayiotis P. |
|
2008 |
|
6 |
p. 757-767 11 p. |
artikel |
4 |
Advances in oral drug delivery: improved bioavailability of poorly absorbed drugs by tissue and cellular optimization
|
Morishita, Mariko |
|
2012 |
|
6 |
p. 479- 1 p. |
artikel |
5 |
Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery
|
Brayden, David J. |
|
2004 |
|
6 |
p. 721-726 6 p. |
artikel |
6 |
Applying the biopharmaceutics classification system to veterinary pharmaceutical products
|
Martinez, Marilyn |
|
2002 |
|
6 |
p. 825-850 26 p. |
artikel |
7 |
Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products
|
Martinez, Marilyn |
|
2002 |
|
6 |
p. 805-824 20 p. |
artikel |
8 |
Approaches for the development of solid and semi-solid lipid-based formulations
|
Jannin, V. |
|
2008 |
|
6 |
p. 734-746 13 p. |
artikel |
9 |
A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery
|
Griffin, J.Frank T |
|
2002 |
|
6 |
p. 851-861 11 p. |
artikel |
10 |
Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations
|
O'Driscoll, C.M. |
|
2008 |
|
6 |
p. 617-624 8 p. |
artikel |
11 |
CAR: A virus receptor within the tight junction
|
Coyne, Carolyn B. |
|
2005 |
|
6 |
p. 869-882 14 p. |
artikel |
12 |
Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration
|
Cole, Ewart T. |
|
2008 |
|
6 |
p. 747-756 10 p. |
artikel |
13 |
Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering
|
Bunjes, Heike |
|
2007 |
|
6 |
p. 379-402 24 p. |
artikel |
14 |
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles
|
Wong, Ho Lun |
|
2007 |
|
6 |
p. 491-504 14 p. |
artikel |
15 |
Controlling drug nanoparticle formation by rapid precipitation
|
D'Addio, Suzanne M. |
|
2011 |
|
6 |
p. 417-426 10 p. |
artikel |
16 |
Corrigendum to “Carbon nanofibers and carbon nanotubes in regenerative medicine”[Advanced Drug Delivery Review 61(2009) 1097–1114]
|
Tran, Phong A. |
|
2010 |
|
6 |
p. 667- 1 p. |
artikel |
17 |
Dendritic cells and oral transmission of prion diseases
|
Huang, Fang-Ping |
|
2004 |
|
6 |
p. 901-913 13 p. |
artikel |
18 |
DNA and carbon nanotubes as medicine
|
Cheung, William |
|
2010 |
|
6 |
p. 633-649 17 p. |
artikel |
19 |
DNA-based nano-sized systems for pharmaceutical and biomedical applications
|
Nishikawa, Makiya |
|
2010 |
|
6 |
p. 626-632 7 p. |
artikel |
20 |
DNA nanomedicine: Engineering DNA as a polymer for therapeutic and diagnostic applications
|
Campolongo, Michael J. |
|
2010 |
|
6 |
p. 606-616 11 p. |
artikel |
21 |
DNA Self-assembly for Nanomedicine
|
Chhabra, Rahul |
|
2010 |
|
6 |
p. 617-625 9 p. |
artikel |
22 |
Drug administration to poultry
|
Vermeulen, B |
|
2002 |
|
6 |
p. 795-803 9 p. |
artikel |
23 |
Editorial Board
|
|
|
2009 |
|
6 |
p. ii- 1 p. |
artikel |
24 |
Editorial Board
|
|
|
2013 |
|
6 |
p. ii- 1 p. |
artikel |
25 |
Editorial Board
|
|
|
2010 |
|
6 |
p. ii- 1 p. |
artikel |
26 |
Editorial Board
|
|
|
2003 |
|
6 |
p. ii- 1 p. |
artikel |
27 |
Editorial Board
|
|
|
2002 |
|
6 |
p. ii- 1 p. |
artikel |
28 |
Editorial Board
|
|
|
2004 |
|
6 |
p. ii- 1 p. |
artikel |
29 |
Editorial Board
|
|
|
2008 |
|
6 |
p. ii- 1 p. |
artikel |
30 |
Editorial Board
|
|
|
2005 |
|
6 |
p. ii- 1 p. |
artikel |
31 |
Editorial Board
|
|
|
2007 |
|
6 |
p. ii- 1 p. |
artikel |
32 |
Editorial Board
|
|
|
2012 |
|
6 |
p. ii- 1 p. |
artikel |
33 |
Editorial Board
|
|
|
2011 |
|
6 |
p. ii- 1 p. |
artikel |
34 |
Effects of nanomaterial physicochemical properties on in vivo toxicity
|
Aillon, Kristin L. |
|
2009 |
|
6 |
p. 457-466 10 p. |
artikel |
35 |
Emerging significance of plasmid DNA nuclear import in gene therapy
|
Munkonge, Felix M. |
|
2003 |
|
6 |
p. 749-760 12 p. |
artikel |
36 |
Engineering RNA for Targeted siRNA Delivery and Medical Application
|
Guo, Peixuan |
|
2010 |
|
6 |
p. 650-666 17 p. |
artikel |
37 |
Enhancing drug absorption using lipids: A case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections
|
Sachs-Barrable, Kristina |
|
2008 |
|
6 |
p. 692-701 10 p. |
artikel |
38 |
Enhancing intestinal drug solubilisation using lipid-based delivery systems
|
Porter, Christopher J.H. |
|
2008 |
|
6 |
p. 673-691 19 p. |
artikel |
39 |
Establishment of Mycobacterium avium subsp. paratuberculosis infection in the intestine of ruminants
|
Sigurðardóttir, Ólöf G |
|
2004 |
|
6 |
p. 819-834 16 p. |
artikel |
40 |
Formation, characterization, and fate of inhaled drug nanoparticles
|
Zhang, Jian |
|
2011 |
|
6 |
p. 441-455 15 p. |
artikel |
41 |
Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies
|
Pouton, Colin W. |
|
2008 |
|
6 |
p. 625-637 13 p. |
artikel |
42 |
From biology to materials: engineering DNA and RNA for drug delivery and nanomedicine
|
Luo, Dan |
|
2010 |
|
6 |
p. 591- 1 p. |
artikel |
43 |
Guide to Authors
|
|
|
2003 |
|
6 |
p. 773-775 3 p. |
artikel |
44 |
Guide to Authors
|
|
|
2002 |
|
6 |
p. 883-885 3 p. |
artikel |
45 |
Guide to Authors
|
|
|
2004 |
|
6 |
p. 921-924 4 p. |
artikel |
46 |
Guide to Authors
|
|
|
2005 |
|
6 |
p. 929-933 5 p. |
artikel |
47 |
Gut-associated lymphoid tissues for the development of oral vaccines
|
Kunisawa, Jun |
|
2012 |
|
6 |
p. 523-530 8 p. |
artikel |
48 |
Helminths at mucosal barriers—interaction with the immune system
|
Mulcahy, Grace |
|
2004 |
|
6 |
p. 853-868 16 p. |
artikel |
49 |
Host intestinal epithelial response to Cryptosporidium parvum
|
Deng, Mingqi |
|
2004 |
|
6 |
p. 869-884 16 p. |
artikel |
50 |
ICAM-1: targeted docking for exogenous as well as endogenous ligands
|
Hopkins, Ann M. |
|
2004 |
|
6 |
p. 763-778 16 p. |
artikel |
51 |
Immunological aspects of controlled antigen delivery
|
Lofthouse, Shari |
|
2002 |
|
6 |
p. 863-870 8 p. |
artikel |
52 |
Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins
|
Fasano, Alessio |
|
2004 |
|
6 |
p. 795-807 13 p. |
artikel |
53 |
In vitro and in vivo models for the study of oral delivery of nanoparticles
|
Gamboa, Jennifer M. |
|
2013 |
|
6 |
p. 800-810 11 p. |
artikel |
54 |
In vitro assessments of nanomaterial toxicity
|
Jones, Clinton F. |
|
2009 |
|
6 |
p. 438-456 19 p. |
artikel |
55 |
Involvement of gut-associated lymphoid tissue of ruminants in the spread of transmissible spongiform encephalopathies
|
Press, Charles McL |
|
2004 |
|
6 |
p. 885-899 15 p. |
artikel |
56 |
Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update
|
Trevaskis, Natalie L. |
|
2008 |
|
6 |
p. 702-716 15 p. |
artikel |
57 |
Lipid-based systems for the enhanced delivery of poorly water soluble drugs
|
Porter, Christopher J.H. |
|
2008 |
|
6 |
p. 615-616 2 p. |
artikel |
58 |
Lipid excipients and delivery systems for pharmaceutical development: A regulatory perspective
|
Chen, Mei-Ling |
|
2008 |
|
6 |
p. 768-777 10 p. |
artikel |
59 |
Lipid nanoparticles for improved topical application of drugs for skin diseases
|
Schäfer-Korting, Monika |
|
2007 |
|
6 |
p. 427-443 17 p. |
artikel |
60 |
Lipid nanoparticles: perspectives and challenges
|
Gasco, Maria Rosa |
|
2007 |
|
6 |
p. 377-378 2 p. |
artikel |
61 |
Lipid nanoparticles: recent advances
|
Müller, Rainer H. |
|
2007 |
|
6 |
p. 375-376 2 p. |
artikel |
62 |
Magnetic nanoparticles for theragnostics
|
Shubayev, Veronica I. |
|
2009 |
|
6 |
p. 467-477 11 p. |
artikel |
63 |
Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt–Jakob disease
|
Ghosh, Subrata |
|
2004 |
|
6 |
p. 915-920 6 p. |
artikel |
64 |
Mechanism of oral tolerance induction to therapeutic proteins
|
Wang, Xiaomei |
|
2013 |
|
6 |
p. 759-773 15 p. |
artikel |
65 |
Mechanisms of nuclear transport and interventions
|
Gasiorowski, Joshua Z. |
|
2003 |
|
6 |
p. 703-716 14 p. |
artikel |
66 |
Microbes and their products—physiological effects upon mammalian mucosa
|
Viswanathan, V.K |
|
2004 |
|
6 |
p. 727-762 36 p. |
artikel |
67 |
Microfabrication technologies for oral drug delivery
|
Sant, Shilpa |
|
2012 |
|
6 |
p. 496-507 12 p. |
artikel |
68 |
Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs
|
Kawakami, Kohsaku |
|
2012 |
|
6 |
p. 480-495 16 p. |
artikel |
69 |
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates
|
Lee, Jung Heon |
|
2010 |
|
6 |
p. 592-605 14 p. |
artikel |
70 |
Molecular mechanisms that regulate transcription factor localization suggest new targets for drug development
|
Lee, Sang-Hyun |
|
2003 |
|
6 |
p. 717-731 15 p. |
artikel |
71 |
Molecular perspective on tight-junction assembly and epithelial polarity
|
Miyoshi, Jun |
|
2005 |
|
6 |
p. 815-855 41 p. |
artikel |
72 |
Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract
|
Kriegel, Christina |
|
2013 |
|
6 |
p. 891-901 11 p. |
artikel |
73 |
Nanodrug particles and nanoformulations for drug delivery
|
Chan, Hak-Kim |
|
2011 |
|
6 |
p. 405- 1 p. |
artikel |
74 |
Nanoparticle- and biomaterials-mediated oral delivery for drug, gene, and immunotherapy
|
Leong, Kam W. |
|
2013 |
|
6 |
p. 757-758 2 p. |
artikel |
75 |
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
|
Aggarwal, Parag |
|
2009 |
|
6 |
p. 428-437 10 p. |
artikel |
76 |
Nanoparticles and microparticles for skin drug delivery
|
Prow, Tarl W. |
|
2011 |
|
6 |
p. 470-491 22 p. |
artikel |
77 |
Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery
|
Yun, Yeonhee |
|
2013 |
|
6 |
p. 822-832 11 p. |
artikel |
78 |
Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology
|
Merisko-Liversidge, Elaine |
|
2011 |
|
6 |
p. 427-440 14 p. |
artikel |
79 |
Nanostructured lipid carriers (NLC) in cosmetic dermal products
|
Müller, R.H. |
|
2007 |
|
6 |
p. 522-530 9 p. |
artikel |
80 |
Nanotoxicity assessment: all small talk?
|
Grainger, David W. |
|
2009 |
|
6 |
p. 419-421 3 p. |
artikel |
81 |
Nuclear transport: an emerging opportunity for drug targeting
|
|
|
2003 |
|
6 |
p. 699-702 4 p. |
artikel |
82 |
Occludin: Structure, function and regulation
|
Feldman, Gemma J. |
|
2005 |
|
6 |
p. 883-917 35 p. |
artikel |
83 |
Oral biodrug delivery using cell-penetrating peptide
|
Khafagy, El-Sayed |
|
2012 |
|
6 |
p. 531-539 9 p. |
artikel |
84 |
Oral colon delivery of insulin with the aid of functional adjuvants
|
Maroni, Alessandra |
|
2012 |
|
6 |
p. 540-556 17 p. |
artikel |
85 |
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells
|
Kwon, Kwang-Chul |
|
2013 |
|
6 |
p. 782-799 18 p. |
artikel |
86 |
Oral delivery of proteins by biodegradable nanoparticles
|
Bakhru, Sasha H. |
|
2013 |
|
6 |
p. 811-821 11 p. |
artikel |
87 |
Oral drug delivery systems using chemical conjugates or physical complexes
|
Al-Hilal, Taslim A. |
|
2013 |
|
6 |
p. 845-864 20 p. |
artikel |
88 |
Oral drug delivery utilizing intestinal OATP transporters
|
Tamai, Ikumi |
|
2012 |
|
6 |
p. 508-514 7 p. |
artikel |
89 |
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
|
Ensign, Laura M. |
|
2012 |
|
6 |
p. 557-570 14 p. |
artikel |
90 |
Oral immunotherapy for food allergy: Clinical and preclinical studies
|
Kulis, Mike |
|
2013 |
|
6 |
p. 774-781 8 p. |
artikel |
91 |
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles
|
Date, Abhijit A. |
|
2007 |
|
6 |
p. 505-521 17 p. |
artikel |
92 |
Pathogen invasion across intestine: mechanisms and potential exploitation
|
Brayden, David J |
|
2004 |
|
6 |
p. 717-719 3 p. |
artikel |
93 |
Pharmaceutical challenges in veterinary product development
|
Ahmed, Imran |
|
2002 |
|
6 |
p. 871-882 12 p. |
artikel |
94 |
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
|
Mei, Lin |
|
2013 |
|
6 |
p. 880-890 11 p. |
artikel |
95 |
Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug
|
Hanafy, A. |
|
2007 |
|
6 |
p. 419-426 8 p. |
artikel |
96 |
Physical and chemical stability of drug nanoparticles
|
Wu, Libo |
|
2011 |
|
6 |
p. 456-469 14 p. |
artikel |
97 |
Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine
|
Crotty, Shane |
|
2004 |
|
6 |
p. 835-852 18 p. |
artikel |
98 |
Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
|
Custodio, Joseph M. |
|
2008 |
|
6 |
p. 717-733 17 p. |
artikel |
99 |
Probiotics in inflammatory bowel disease—therapeutic rationale and role
|
Shanahan, Fergus |
|
2004 |
|
6 |
p. 809-818 10 p. |
artikel |
100 |
Production methods for nanodrug particles using the bottom-up approach
|
Chan, Hak-Kim |
|
2011 |
|
6 |
p. 406-416 11 p. |
artikel |
101 |
Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system
|
Chattopadhyay, P. |
|
2007 |
|
6 |
p. 444-453 10 p. |
artikel |
102 |
Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium: bacterial targets linked to nutrient absorption
|
Taı̈eb, Nadira |
|
2004 |
|
6 |
p. 779-794 16 p. |
artikel |
103 |
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
|
Chen, Mei-Chin |
|
2013 |
|
6 |
p. 865-879 15 p. |
artikel |
104 |
Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs
|
Zolnik, Banu S. |
|
2009 |
|
6 |
p. 422-427 6 p. |
artikel |
105 |
Role of claudins in tumorigenesis
|
Swisshelm, Karen |
|
2005 |
|
6 |
p. 919-928 10 p. |
artikel |
106 |
Role of the cytoskeleton in nuclear import
|
Campbell, Edward M. |
|
2003 |
|
6 |
p. 761-771 11 p. |
artikel |
107 |
Solid lipid nanoparticles as a drug delivery system for peptides and proteins
|
Almeida, António J. |
|
2007 |
|
6 |
p. 478-490 13 p. |
artikel |
108 |
Solid lipid nanoparticles for targeted brain drug delivery
|
Blasi, Paolo |
|
2007 |
|
6 |
p. 454-477 24 p. |
artikel |
109 |
Spiral progression in the development of absorption enhancers based on the biology of tight junctions
|
Kondoh, Masuo |
|
2012 |
|
6 |
p. 515-522 8 p. |
artikel |
110 |
Stability of lipid excipients in solid lipid nanoparticles
|
Radomska-Soukharev, Anna |
|
2007 |
|
6 |
p. 411-418 8 p. |
artikel |
111 |
Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy
|
Blaschke, T. |
|
2007 |
|
6 |
p. 403-410 8 p. |
artikel |
112 |
Targeted nanoparticles with novel non-peptidic ligands for oral delivery
|
des Rieux, Anne |
|
2013 |
|
6 |
p. 833-844 12 p. |
artikel |
113 |
The JAM family of proteins
|
Mandell, Kenneth J. |
|
2005 |
|
6 |
p. 857-867 11 p. |
artikel |
114 |
Tight junctions, from tight intercellular seals to sophisticated protein complexes involved in drug delivery, pathogens interaction and cell proliferation
|
Gonzalez-Mariscal, Lorenza |
|
2005 |
|
6 |
p. 811-814 4 p. |
artikel |
115 |
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
|
Sadekar, S. |
|
2012 |
|
6 |
p. 571-588 18 p. |
artikel |
116 |
Veterinary drug delivery (Part V)
|
|
|
2002 |
|
6 |
p. 785- 1 p. |
artikel |
117 |
Virus nuclear import
|
Whittaker, Gary R. |
|
2003 |
|
6 |
p. 733-747 15 p. |
artikel |
118 |
What determines drug solubility in lipid vehicles: Is it predictable?
|
Rane, Sagar S. |
|
2008 |
|
6 |
p. 638-656 19 p. |
artikel |
119 |
Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity
|
Fako, Valerie E. |
|
2009 |
|
6 |
p. 478-486 9 p. |
artikel |
120 |
Zoological pharmacology: current status, issues, and potential
|
Hunter, Robert P |
|
2002 |
|
6 |
p. 787-793 7 p. |
artikel |